Home

Psyence Biomedical Ltd. - Ordinary Shares (PBM)

1.5700
-0.0500 (-3.09%)

Psyence Biomedical Ltd. is a leading biotechnology company focused on harnessing the therapeutic potential of psychedelics to develop innovative treatments for mental health conditions and other ailments

The company is dedicated to conducting research and clinical trials to better understand the efficacy and safety of its psychedelic compounds, aiming to advance the field of mental health care. Through the development of proprietary formulations and treatment protocols, Psyence strives to create evidence-based solutions that can improve the quality of life for patients suffering from conditions such as depression, anxiety, and post-traumatic stress disorder.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close1.620
Open1.600
Bid1.540
Ask1.580
Day's Range1.530 - 1.600
52 Week Range1.210 - 323.25
Volume66,550
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume502,900

News & Press Releases

12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 23, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 20, 2024
Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · December 20, 2024
US Stocks To Open Lower As Traders Brace For 'Triple Witching' Hour: Analyst Says End Of The Year Recovery 'Would Not Surprise Anyone'benzinga.com
U.S. futures declined on Friday, ahead of the 'Triple Witching' hour, which is expected to see $6.6 trillion options expire, for the quarter.
Via Benzinga · December 20, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 19, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 10, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 9, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 6, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 5, 2024
“Power Nickel (TSX.V: PNPN) (OTCQB: PNPNF) Announces Dividend – MIGI, PRFX, PBM, CSDX Stocks Trending Now!”
Today's market update highlights exciting developments across key companies demonstrating innovation, growth potential, and strategic progress. From dividend shares and stock splits to groundbreaking medical advancements, these companies offer compelling opportunities for investors to watch.
Via AB Newswire · December 5, 2024
Why Verint Systems Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · December 5, 2024
Psyence Biomedical Secures Extension To Meet Nasdaq Compliance Standardsbenzinga.com
Psyence Biomed secures Nasdaq extension to meet compliance by December 31, advancing psilocybin-based therapeutics for mental health treatments.
Via Benzinga · November 20, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 13, 2024
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · November 7, 2024
10 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 4, 2024
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · November 1, 2024
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · October 31, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 31, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · October 9, 2024
Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisitionbenzinga.com
Psyence Biomed launches Phase IIb trials for psilocybin in palliative care and Alcohol Use Disorder, bolstering its clinical pipeline with key acquisitions and partnerships.
Via Benzinga · September 16, 2024
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · September 16, 2024
Psyence Biomed Launches First Trial Site In Australia For Phase IIb Psilocybin Study In Palliative Carebenzinga.com
Psyence Biomed initiates a Phase IIb psilocybin trial in Australia to explore its potential as a treatment for Adjustment Disorder.
Via Benzinga · September 9, 2024
Crude Oil Down 1%; Dollar Tree Shares Tumble After Downbeat Earningsbenzinga.com
Via Benzinga · September 4, 2024
Psyence Biomedical (PBM) Stock Is Down 30%: What's Going On?benzinga.com
Psyence Biomedical shares are trading lower by 34% during Wednesday's session. The company announced an exclusive licensing agreement with PsyLabs.
Via Benzinga · September 4, 2024
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionbenzinga.com
Via Benzinga · July 25, 2024